GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.30 $3.29 Thursday, 18th Apr 2024 ABUS stock ended at $2.73. This is 1.80% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.72% from a day low at $2.69 to a day high of $2.79.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
2024-04-18 $2.78 $2.79 $2.69 $2.73 988 339
2024-04-17 $2.91 $2.94 $2.78 $2.78 680 679
2024-04-16 $2.89 $2.94 $2.88 $2.92 638 738
2024-04-15 $2.90 $2.99 $2.82 $2.97 3 616 986
2024-04-12 $2.99 $3.03 $2.90 $2.91 657 294
2024-04-11 $2.95 $3.05 $2.94 $3.03 832 493
2024-04-10 $3.01 $3.02 $2.90 $2.98 1 104 884
2024-04-09 $3.06 $3.11 $3.00 $3.01 796 742
2024-04-08 $3.17 $3.19 $3.03 $3.09 1 218 381
2024-04-05 $3.02 $3.29 $2.98 $3.12 6 075 330
2024-04-04 $2.93 $3.11 $2.86 $3.00 8 055 108
2024-04-03 $2.51 $3.25 $2.30 $2.92 12 399 405
2024-04-02 $2.52 $2.54 $2.49 $2.52 440 525
2024-04-01 $2.61 $2.61 $2.55 $2.56 480 974
2024-03-28 $2.59 $2.61 $2.55 $2.58 509 565
2024-03-27 $2.49 $2.60 $2.48 $2.60 815 074
2024-03-26 $2.53 $2.53 $2.48 $2.49 368 527
2024-03-25 $2.51 $2.54 $2.49 $2.49 331 415
2024-03-22 $2.55 $2.55 $2.50 $2.50 326 456
2024-03-21 $2.57 $2.60 $2.53 $2.55 572 759
2024-03-20 $2.49 $2.57 $2.42 $2.55 699 921
2024-03-19 $2.52 $2.58 $2.49 $2.50 394 219
2024-03-18 $2.63 $2.64 $2.54 $2.54 600 963
2024-03-15 $2.59 $2.63 $2.56 $2.62 1 165 940
2024-03-14 $2.68 $2.69 $2.59 $2.61 812 322
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT